BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3010623)

  • 1. Characterization of immunoreactive corticotropin and corticotropin-releasing factor in human adrenal and ovarian tumours.
    Suda T; Tomori N; Yajima F; Odagiri E; Demura H; Shizume K
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):546-52. PubMed ID: 3010623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma.
    Suda T; Tomori N; Tozawa F; Demura H; Shizume K; Mouri T; Miura Y; Sasano N
    J Clin Endocrinol Metab; 1984 May; 58(5):919-24. PubMed ID: 6323518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues.
    Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1984 Nov; 59(5):861-6. PubMed ID: 6332825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phaeochromocytoma presenting with Cushing's syndrome associated with increased concentrations of circulating corticotrophin-releasing factor.
    Jessop DS; Cunnah D; Millar JG; Neville E; Coates P; Doniach I; Besser GM; Rees LH
    J Endocrinol; 1987 Apr; 113(1):133-8. PubMed ID: 3035046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides related to the N-terminus of pro-opiomelanocortin in the human adrenal medulla.
    Gaspar L; Chan JS; Seidah NG; Chrétien M
    Clin Invest Med; 1989 Apr; 12(2):90-8. PubMed ID: 2539931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
    Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor in the adrenal medulla.
    Bruhn TO; Engeland WC; Anthony EL; Gann DS; Jackson IM
    Ann N Y Acad Sci; 1987; 512():115-28. PubMed ID: 3502062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and hypothalamic hormones in normal and neoplastic adrenal medullae: biologically active corticotropin-releasing hormone and corticotropin.
    Nicholson WE; DeCherney GS; Jackson RV; Orth DN
    Regul Pept; 1987 Aug; 18(3-4):173-88. PubMed ID: 2823321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and immunological characterization of corticotropin-releasing activity in the bovine adrenal medulla.
    Minamino N; Uehara A; Arimura A
    Peptides; 1988; 9(1):37-45. PubMed ID: 2834703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla.
    Hashimoto K; Murakami K; Hattori T; Niimi M; Fujino K; Ota Z
    Peptides; 1984; 5(4):707-11. PubMed ID: 6333676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
    Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
    Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia with Cushing's syndrome due to paraganglioma producing corticotropin-releasing factor and adrenocorticotropin.
    Hashimoto K; Suemaru S; Hattori T; Sugawara M; Ota Z; Takata S; Hamaya K; Doi K; Chrétien M
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):189-95. PubMed ID: 2877533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of corticotropin-releasing factor-like immunoreactivity in human tumors.
    Wakabayashi I; Ihara T; Hattori M; Tonegawa Y; Shibasaki T; Hashimoto K
    Cancer; 1985 Mar; 55(5):995-1000. PubMed ID: 3871347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
    Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRF immunoreactive peptides in the human hypophysis: a cautionary note.
    Bény JL; Corder R; Nieuwenhuijzen Kruseman AC; Lowry PJ
    Peptides; 1985; 6(4):661-7. PubMed ID: 2999732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA; Stalla GK; von Werder K
    Horm Res; 1987; 25(4):185-98. PubMed ID: 3034758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of circulating corticotrophin-releasing factor in man.
    Cunnah D; Jessop DS; Besser GM; Rees LH
    J Endocrinol; 1987 Apr; 113(1):123-31. PubMed ID: 3035045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of corticotropin-releasing factor and adrenocorticotropic hormone in the ovarian maturation, seawater acclimation, and induced spawning of Liza ramada.
    Mousa SA; Mousa MA
    Gen Comp Endocrinol; 2006 Apr; 146(2):167-79. PubMed ID: 16376890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor test in normal subjects and patients with hypothalamic-pituitary-adrenal disorders.
    Nakahara M; Shibasaki T; Shizume K; Kiyosawa Y; Odagiri E; Suda T; Yamaguchi H; Tsushima T; Demura H; Maeda T
    J Clin Endocrinol Metab; 1983 Nov; 57(5):963-8. PubMed ID: 6311867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.